Compared with T1 stage BC patients, T2 stage BC patients tend to have higher expression of CDC20 and UBE2S (Fig. 5A and Figure S2, Supplemental Digital Content 2, http://links.lww.com/MD/H330). This evidence concerns the gene UBE2S and breast cancer.